Liver Elastography for Fibrosis Assessment

Introduction to Liver Elastography

Liver elastography is a noninvasive imaging technique that measures liver stiffness as a surrogate biomarker for liver fibrosis, with the American Association for the Study of Liver Diseases recommending its use for fibrosis assessment 1, 2

Transient Elastography (TE) is the most commonly used method in clinical practice, performed with devices like FibroScan, and requires a minimum of 10 valid liver stiffness measurements to derive a composite score, with adequate quality defined as ≥10 validated measurements and interquartile range/median value ≤30%, as per the European Association for the Study of the Liver 3, 5
Shear Wave Elastography (SWE) uses acoustic radiation force impulse imaging to generate shear waves through acoustic vibrations, and can be combined with conventional ultrasound, with the American College of Radiology recommending its use in patients with obesity, ascites, and NAFLD 2, 7
Magnetic Resonance Elastography (MRE) appears to be the most accurate method for detecting liver fibrosis, permitting assessment of the whole liver rather than a limited sampling area, with the American Association for the Study of Liver Diseases recommending its use for fibrosis assessment 1, 8

For significant fibrosis (F2-4), sensitivities range from 51-95%, specificities from 36-100% across all techniques and diseases, with the highest accuracy for cirrhosis (F4), as reported by the American Association for the Study of Liver Diseases 1, 8
VCTE demonstrates sensitivity of 0.89 and specificity of 0.91 for diagnosing cirrhosis, with the European Association for the Study of the Liver recommending its use for fibrosis assessment 3, 4

Obesity, ascites, and narrow intercostal spaces are technical limitations of TE, with failure rates ranging from 1.1-3.5% in Asian populations and 4.3-10.5% in Western populations, as reported by the American College of Radiology 3, 7
Active hepatitis/inflammation, recent food intake, alcohol abuse, vascular congestion, and extrahepatic cholestasis can falsely elevate stiffness values, with the American Association for the Study of Liver Diseases recommending careful consideration of these factors when interpreting elastography results 2, 8, 12

Elastography can be used to predict liver decompensation risk and clinical outcomes in patients with cirrhosis, with the American Association for the Study of Liver Diseases recommending its use for this purpose 9, 10
Elastography can be used to monitor response to treatment in chronic liver disease, though changes may reflect inflammation resolution rather than fibrosis improvement, as reported by the European Association for the Study of the Liver 9, 10

Elastography has emerged as the preferred noninvasive alternative to liver biopsy, which has significant limitations including invasiveness, pain, and mortality, with the American Association for the Study of Liver Diseases recommending elastography as a first-line diagnostic tool 3, 5, 9